Name | Number of supported studies | Average coverage | |
---|---|---|---|
type I pneumocyte | 12 studies | 44% ± 14% | |
glutamatergic neuron | 9 studies | 37% ± 24% | |
oligodendrocyte | 9 studies | 25% ± 8% | |
endothelial cell of lymphatic vessel | 8 studies | 27% ± 14% | |
type II pneumocyte | 7 studies | 28% ± 7% | |
ciliated cell | 6 studies | 23% ± 7% | |
GABAergic neuron | 6 studies | 39% ± 22% | |
interneuron | 5 studies | 35% ± 22% | |
epithelial cell | 5 studies | 30% ± 15% | |
neuron | 4 studies | 32% ± 9% | |
endothelial cell | 4 studies | 30% ± 7% | |
retinal ganglion cell | 4 studies | 53% ± 28% | |
retina horizontal cell | 4 studies | 25% ± 8% | |
club cell | 4 studies | 29% ± 8% | |
placental villous trophoblast | 3 studies | 36% ± 17% | |
amacrine cell | 3 studies | 34% ± 7% | |
basal cell | 3 studies | 28% ± 10% | |
granule cell | 3 studies | 28% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 99% | 1961.04 | 648 / 653 | 99% | 12.04 | 598 / 605 |
lung | 98% | 2781.83 | 568 / 578 | 99% | 10.29 | 1142 / 1155 |
brain | 99% | 5881.48 | 2617 / 2642 | 93% | 11.18 | 657 / 705 |
kidney | 99% | 1083.97 | 88 / 89 | 90% | 4.81 | 814 / 901 |
prostate | 76% | 745.30 | 187 / 245 | 99% | 10.14 | 499 / 502 |
adrenal gland | 94% | 848.44 | 243 / 258 | 79% | 6.39 | 181 / 230 |
pancreas | 72% | 501.69 | 235 / 328 | 97% | 7.16 | 173 / 178 |
stomach | 61% | 459.05 | 218 / 359 | 98% | 9.26 | 279 / 286 |
skin | 70% | 757.33 | 1275 / 1809 | 81% | 5.48 | 380 / 472 |
intestine | 47% | 647.29 | 450 / 966 | 99% | 9.46 | 520 / 527 |
esophagus | 40% | 445.77 | 579 / 1445 | 100% | 10.46 | 183 / 183 |
breast | 36% | 256.10 | 164 / 459 | 96% | 6.46 | 1070 / 1118 |
bladder | 29% | 212.52 | 6 / 21 | 96% | 8.53 | 485 / 504 |
liver | 51% | 365.64 | 116 / 226 | 64% | 2.62 | 261 / 406 |
ovary | 7% | 48.52 | 13 / 180 | 98% | 8.35 | 422 / 430 |
tonsil | 0% | 0 | 0 / 0 | 100% | 6.52 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.08 | 1 / 1 |
spleen | 99% | 957.91 | 239 / 241 | 0% | 0 | 0 / 0 |
uterus | 4% | 26.49 | 7 / 170 | 91% | 7.24 | 416 / 459 |
eye | 0% | 0 | 0 / 0 | 86% | 6.13 | 69 / 80 |
lymph node | 0% | 0 | 0 / 0 | 66% | 3.22 | 19 / 29 |
heart | 54% | 393.74 | 464 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 35% | 295.66 | 322 / 929 | 0% | 0 | 0 / 0 |
adipose | 0% | 3.00 | 6 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 2.45 | 6 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030010 | Biological process | establishment of cell polarity |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_0072659 | Biological process | protein localization to plasma membrane |
GO_0006954 | Biological process | inflammatory response |
GO_0051899 | Biological process | membrane depolarization |
GO_0032869 | Biological process | cellular response to insulin stimulus |
GO_0032753 | Biological process | positive regulation of interleukin-4 production |
GO_0007616 | Biological process | long-term memory |
GO_0007165 | Biological process | signal transduction |
GO_0032736 | Biological process | positive regulation of interleukin-13 production |
GO_0031333 | Biological process | negative regulation of protein-containing complex assembly |
GO_0001954 | Biological process | positive regulation of cell-matrix adhesion |
GO_0032733 | Biological process | positive regulation of interleukin-10 production |
GO_0046627 | Biological process | negative regulation of insulin receptor signaling pathway |
GO_0060291 | Biological process | long-term synaptic potentiation |
GO_2000463 | Biological process | positive regulation of excitatory postsynaptic potential |
GO_2000553 | Biological process | positive regulation of T-helper 2 cell cytokine production |
GO_0050732 | Biological process | negative regulation of peptidyl-tyrosine phosphorylation |
GO_0045197 | Biological process | establishment or maintenance of epithelial cell apical/basal polarity |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0060081 | Biological process | membrane hyperpolarization |
GO_0032754 | Biological process | positive regulation of interleukin-5 production |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0051222 | Biological process | positive regulation of protein transport |
GO_0000226 | Biological process | microtubule cytoskeleton organization |
GO_0046628 | Biological process | positive regulation of insulin receptor signaling pathway |
GO_0098696 | Biological process | regulation of neurotransmitter receptor localization to postsynaptic specialization membrane |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_1990138 | Biological process | neuron projection extension |
GO_0070528 | Biological process | protein kinase C signaling |
GO_0006468 | Biological process | protein phosphorylation |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0016477 | Biological process | cell migration |
GO_0047496 | Biological process | vesicle transport along microtubule |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0045630 | Biological process | positive regulation of T-helper 2 cell differentiation |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0070160 | Cellular component | tight junction |
GO_0031982 | Cellular component | vesicle |
GO_0098685 | Cellular component | Schaffer collateral - CA1 synapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0016020 | Cellular component | membrane |
GO_0005815 | Cellular component | microtubule organizing center |
GO_0043203 | Cellular component | axon hillock |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005635 | Cellular component | nuclear envelope |
GO_0031252 | Cellular component | cell leading edge |
GO_0045179 | Cellular component | apical cortex |
GO_0005911 | Cellular component | cell-cell junction |
GO_0016363 | Cellular component | nuclear matrix |
GO_0001725 | Cellular component | stress fiber |
GO_0005829 | Cellular component | cytosol |
GO_0120157 | Cellular component | PAR polarity complex |
GO_0035748 | Cellular component | myelin sheath abaxonal region |
GO_0014069 | Cellular component | postsynaptic density |
GO_0005737 | Cellular component | cytoplasm |
GO_0005923 | Cellular component | bicellular tight junction |
GO_0030054 | Cellular component | cell junction |
GO_0005768 | Cellular component | endosome |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0019901 | Molecular function | protein kinase binding |
GO_0071889 | Molecular function | 14-3-3 protein binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0043560 | Molecular function | insulin receptor substrate binding |
GO_0004672 | Molecular function | protein kinase activity |
GO_0043274 | Molecular function | phospholipase binding |
GO_0015459 | Molecular function | potassium channel regulator activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0004697 | Molecular function | diacylglycerol-dependent serine/threonine kinase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PRKCZ |
Protein name | Protein kinase C zeta type (EC 2.7.11.13) (nPKC-zeta) Protein kinase C zeta |
Synonyms | PKC2 |
Description | FUNCTION: Calcium- and diacylglycerol-independent serine/threonine-protein kinase that functions in phosphatidylinositol 3-kinase (PI3K) pathway and mitogen-activated protein (MAP) kinase cascade, and is involved in NF-kappa-B activation, mitogenic signaling, cell proliferation, cell polarity, inflammatory response and maintenance of long-term potentiation (LTP). Upon lipopolysaccharide (LPS) treatment in macrophages, or following mitogenic stimuli, functions downstream of PI3K to activate MAP2K1/MEK1-MAPK1/ERK2 signaling cascade independently of RAF1 activation. Required for insulin-dependent activation of AKT3, but may function as an adapter rather than a direct activator. Upon insulin treatment may act as a downstream effector of PI3K and contribute to the activation of translocation of the glucose transporter SLC2A4/GLUT4 and subsequent glucose transport in adipocytes. In EGF-induced cells, binds and activates MAP2K5/MEK5-MAPK7/ERK5 independently of its kinase activity and can activate JUN promoter through MEF2C. Through binding with SQSTM1/p62, functions in interleukin-1 signaling and activation of NF-kappa-B with the specific adapters RIPK1 and TRAF6. Participates in TNF-dependent transactivation of NF-kappa-B by phosphorylating and activating IKBKB kinase, which in turn leads to the degradation of NF-kappa-B inhibitors. In migrating astrocytes, forms a cytoplasmic complex with PARD6A and is recruited by CDC42 to function in the establishment of cell polarity along with the microtubule motor and dynein. In association with FEZ1, stimulates neuronal differentiation in PC12 cells. In the inflammatory response, is required for the T-helper 2 (Th2) differentiation process, including interleukin production, efficient activation of JAK1 and the subsequent phosphorylation and nuclear translocation of STAT6. May be involved in development of allergic airway inflammation (asthma), a process dependent on Th2 immune response. In the NF-kappa-B-mediated inflammatory response, can relieve SETD6-dependent repression of NF-kappa-B target genes by phosphorylating the RELA subunit at 'Ser-311'. Phosphorylates VAMP2 in vitro . .; FUNCTION: [Isoform 2]: Involved in late synaptic long term potention phase in CA1 hippocampal cells and long term memory maintenance. . |
Accessions | ENST00000468310.5 ENST00000470596.5 ENST00000496325.5 ENST00000497183.5 ENST00000471018.6 ENST00000378567.8 [Q05513-1] D6RAN5 D6RC84 ENST00000470511.5 F2Z3C5 ENST00000466352.5 D6RBD4 E9PBE1 D6RCN4 ENST00000461465.5 D6RD31 ENST00000470986.5 ENST00000486681.5 D6RDM0 ENST00000478770.6 F2Z2H9 J3KRP7 ENST00000503297.1 ENST00000482686.5 D6RAU1 D6REZ8 D6RJG4 ENST00000495347.5 ENST00000461106.6 [Q05513-3] ENST00000400921.6 [Q05513-2] Q05513 D6RGG1 D6RG01 ENST00000481140.5 |